| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 23.12. | Inspira Technologies reaffirms $49.5 million in purchase orders | 3 | Investing.com | ||
| 23.12. | Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones | 227 | GlobeNewswire (Europe) | RA'ANANA, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira" or the "Company"), a pioneer in innovative life-support and diagnostic technologies... ► Artikel lesen | |
| 23.12. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22.12. | Inspira Technologies OXY B.H.N. Ltd - F-1, Registration statement for certain foreign private issuers | - | SEC Filings | ||
| 15.12. | Inspira Technologies: Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution | 1 | GlobeNewswire (USA) | ||
| 15.12. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 09.12. | Inspira Technologies secures Japanese patent for dual lumen cannula | 2 | Investing.com | ||
| 09.12. | Inspira Technologies Granted Patent in Japan for the INSPIRA ART System's Convertible Dual Lumen Cannula Device and Method of Use | 8 | GlobeNewswire (USA) | ||
| INSPIRA TECHNOLOGIES OXY BHN Aktie jetzt für 0€ handeln | |||||
| 03.12. | Inspira Technologies Announces Strategic Leap in Lab Capabilities - Accelerating Next-Generation Diagnostics and Blood Technology | 3 | GlobeNewswire (USA) | ||
| 03.12. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 25.11. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 13.11. | Inspira Technologies: Inspira Completes Clinical Study for HYLA Blood Sensor - Ahead of Regulatory Submission | 128 | GlobeNewswire (Europe) | RA'ANANA, Israel, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 13.11. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 06.11. | Inspira Technologies submits FDA-cleared ART100 system to UAE health ministry | 1 | Investing.com | ||
| 06.11. | Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion | 1 | GlobeNewswire (USA) | ||
| 06.11. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | - | SEC Filings | ||
| 22.10. | Inspira Technologies partners with Bites for AI-powered training | 2 | Investing.com | ||
| 22.10. | Inspira Technologies: Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem | 1 | GlobeNewswire (USA) | ||
| 21.10. | Inspira Technologies: Inspira Appoints Former Johnson & Johnson Senior Business Manager as VP of Global Sales and New Board Member from a Leading International Investment Firm | 310 | GlobeNewswire (Europe) | RA'ANANA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inspira Technologies OXY B.H.N. Ltd. (NASDAQ: IINN) ("Inspira," "Inspira Technologies," or the "Company"), a pioneer in innovative life-support... ► Artikel lesen | |
| 21.10. | Inspira Technologies OXY B.H.N. Ltd - 6-K, Report of foreign issuer | 1 | SEC Filings |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS | 48,690 | -0,14 % | Amneal Pharma, MAbxience: FDA Approves Denosumab Biosimilars Referencing Amgen's Prolia And XGEVA | THOUSAND OAKS (dpa-AFX) - Amneal Pharmaceuticals, Inc. (AMRX) announced late Monday that the U.S. Food and Drug Administration has approved the Biologics Licensing Applications or BLAs for Boncresa... ► Artikel lesen | |
| UNITEDHEALTH | 279,45 | 0,00 % | Morgen-Update: Unitedhealth-Aktie explodiert - Anleger im Kaufrausch! | ||
| MEDTRONIC | 81,80 | +0,13 % | Dividendenbekanntmachungen (26.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ALERUS FINANCIAL CORPORATION US01446U1034 0,21 USD 0,1782 EUR ALTRIA GROUP INC US02209S1033 1,06 USD 0,8999 EUR ARROWMARK FINANCIAL... ► Artikel lesen | |
| GERRESHEIMER | 27,580 | +2,53 % | Gerresheimer-Aktie: Gute Einstiegschance? | Aktionäre von Gerresheimer mussten im laufenden Jahr erhebliche Verluste hinnehmen. Der Kurs sank von 70 € zum Jahresbeginn bis auf 23,50 €. Zuletzt konnte er sich wieder berappeln und steht am Montag... ► Artikel lesen | |
| THERMO FISHER | 496,00 | -0,21 % | Favorable Results and Improved Guidance Lifted Thermo Fisher Scientific (TMO) in Q3 | ||
| HIMS & HERS HEALTH | 28,980 | +0,03 % | TEM vs. HIMS: Which Medical Info Systems Stock Offers Greater Upside | ||
| BOSTON SCIENTIFIC | 81,60 | +0,25 % | A Strong Growth Profile Gives Boston Scientific Corp. (BSX) a Favorable Outlook | ||
| RESMED | 206,50 | +0,10 % | Resmed Gets FDA Clearance For Personalized Therapy Comfort Settings; To Be Marketed As Smart Comfort | WASHINGTON (dpa-AFX) - Resmed (RMD, RMD.AX), Monday announced it has received U.S. Food and Drug Administration (FDA) clearance for Personalized Therapy Comfort Settings (PTCS), to be marketed... ► Artikel lesen | |
| CARDINAL HEALTH | 176,80 | +0,34 % | Cardinal Health completes acquisition of Solaris Health | Adds the country's leading urology MSO with over 750 providers to Cardinal Health's leading multi-specialty MSO platform, The Specialty Alliance and brings Cardinal... ► Artikel lesen | |
| MCKESSON | 705,20 | -0,03 % | Dividendenbekanntmachungen (01.12.2025) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ACNB CORPORATION US0008681092 0,38 USD 0,3276 EUR ADVANCED DRAINAGE SYSTEMS INC US00790R1041 0,18 USD 0,1551 EUR AGNICO EAGLE MINES... ► Artikel lesen | |
| OTTOBOCK | 65,25 | +0,69 % | Aktien Frankfurt: Dax vorweihnachtlich träge | FRANKFURT (dpa-AFX) - Nach den moderaten Gewinnen am Freitag ist der deutsche Aktienmarkt etwas schwächer in die kurze Handelswoche vor Weihnachten gestartet. Das Geschehen ist von einem deutlich geringeren... ► Artikel lesen | |
| SOLVENTUM | 68,20 | 0,00 % | Solventum Completes Acquisition of Acera Surgical | Expands MedSurg portfolio into the fast-growing synthetic tissue matrices technology space in acute care settings in the U.S.
Accelerates Solventum's business... ► Artikel lesen | |
| ZIMMER BIOMET | 76,80 | -0,16 % | Bactiguard Holding AB: Bactiguard announces updated trauma license agreement with Zimmer Biomet | Bactiguard continues the collaboration with Zimmer Biomet in an updated agreement, giving Zimmer Biomet non-exclusive rights to continue to commercialize the ZNN Bactiguard coated trauma nail system... ► Artikel lesen | |
| CENTENE | 34,600 | -0,25 % | Centene Corporation Reports Third Quarter 2025 Results | -- GAAP Diluted Loss Per Share of $(13.50); Adjusted Diluted Earnings Per Share of $0.50 --
Adjusted diluted EPS of $0.50 in the third quarter of 2025, including... ► Artikel lesen | |
| INSULET | 244,30 | +0,04 % | Insulet: FDA Approves Enhancements To Omnipod 5 Algorithm | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - Insulet (PODD) announced it has received FDA 510(k) clearance for significant enhancements to the Omnipod 5 Automated Insulin Delivery System. The new 100... ► Artikel lesen |